{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:18:14Z","timestamp":1789417094793,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jcv.2022.105375","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T20:05:06Z","timestamp":1671825906000},"page":"105375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["A longitudinal study to detect hepatitis B surface and core-related antigens in chronic hepatitis B patients with hepatitis B surface antigen seroclearance using highly sensitive assays"],"prefix":"10.1016","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9078-5005","authenticated-orcid":false,"given":"Danny Ka-Ho","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lung-Yi","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rex Wan-Hin","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Shing","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-Kay","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Fung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2022.105375_bib0001","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.10.027","article-title":"Factors associated with rates of HBsAg Seroclearance in adults with chronic HBV infection: a systematic review and meta-analysis","volume":"156","author":"Yeo","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcv.2022.105375_bib0002","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1053\/j.gastro.2008.07.008","article-title":"HBsAg seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma","volume":"135","author":"Yuen","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcv.2022.105375_bib0003","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.10.038","article-title":"American gastroenterological association institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","author":"Perrillo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcv.2022.105375_bib0004","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/apt.14376","article-title":"Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection","volume":"47","author":"Mak","year":"2018","journal-title":"Alimentary Pharmacol. Therapeutics"},{"key":"10.1016\/j.jcv.2022.105375_bib0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-022-00649-z","article-title":"A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook","author":"Kramvis","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jcv.2022.105375_bib0006","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/1469-0691.12739","article-title":"Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B","volume":"20","author":"Seto","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jcv.2022.105375_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.02.010","article-title":"Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D","volume":"21","author":"Maasoumy","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jcv.2022.105375_bib0008","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/liv.13346","article-title":"Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA","volume":"37","author":"Wong","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.jcv.2022.105375_bib0009","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jhep.2018.11.030","article-title":"Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients","volume":"70","author":"Testoni","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2022.105375_bib0010","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/jvh.12688","article-title":"Relationship between HBsAg, HBcrAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos(t)ide therapy","volume":"24","author":"Cheung","year":"2017","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.jcv.2022.105375_bib0011","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/apt.15108","article-title":"Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues","volume":"49","author":"Hosaka","year":"2019","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.jcv.2022.105375_bib0012","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1111\/jgh.15563","article-title":"Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patients","volume":"36","author":"Kaneko","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jcv.2022.105375_bib0013","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/JCM.40.2.439-445.2002","article-title":"Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load","volume":"40","author":"Kimura","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2022.105375_bib0014","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12072-012-9354-7","article-title":"Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay","volume":"7","author":"Seto","year":"2013","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jcv.2022.105375_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.02204-21","article-title":"Detection of the hepatitis B surface antigen in patients with occult hepatitis B by use of an assay with enhanced sensitivity","volume":"60","author":"Wong","year":"2022","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2022.105375_bib0016","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00535-016-1244-7","article-title":"Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody","volume":"52","author":"Matsumoto","year":"2017","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jcv.2022.105375_bib0017","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhep.2021.02.017","article-title":"Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation","volume":"75","author":"Inoue","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2022.105375_bib0018","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1093\/infdis\/jiz038","article-title":"A territorywide prevalence study on blood-borne and enteric viral hepatitis in Hong Kong","volume":"219","author":"Liu","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2022.105375_bib0019","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3350\/cmh.2020.0115","article-title":"Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance","volume":"27","author":"Jang","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.jcv.2022.105375_bib0020","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cgh.2019.06.029","article-title":"Among patients with undetectable hepatitis b surface antigen and hepatocellular carcinoma, a high proportion has integration of HBV DNA into hepatocyte DNA and no cirrhosis","volume":"18","author":"Wong","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jcv.2022.105375_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.10.036","article-title":"Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection","volume":"22","author":"Wong","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jcv.2022.105375_bib0022","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(05)67568-X","article-title":"Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study","volume":"366","author":"Zanetti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2022.105375_bib0023","doi-asserted-by":"crossref","DOI":"10.1007\/s00535-022-01872-w","article-title":"Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation","author":"Suzuki","year":"2022","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jcv.2022.105375_bib0024","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.13761","article-title":"Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core-related antigen assay","author":"Hagiwara","year":"2022","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jcv.2022.105375_bib0025","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/ajg.2016.436","article-title":"Association of hepatitis B Core-related antigen with hepatitis B virus reactivation in occult viral carriers undergoing high-risk immunosuppressive therapy","volume":"111","author":"Seto","year":"2016","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jcv.2022.105375_bib0026","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2022.105375_bib0027","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2022.105375_bib0028","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s12072-021-10223-5","article-title":"APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients","volume":"15","author":"Kao","year":"2021","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jcv.2022.105375_bib0029","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/jvh.13191","article-title":"Hepatitis B core-related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinoma","volume":"26","author":"To","year":"2019","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.jcv.2022.105375_bib0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH Clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","year":"2015","journal-title":"J. Hepatol."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653222003079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653222003079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:16:56Z","timestamp":1761362216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653222003079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":30,"alternative-id":["S1386653222003079"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2022.105375","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A longitudinal study to detect hepatitis B surface and core-related antigens in chronic hepatitis B patients with hepatitis B surface antigen seroclearance using highly sensitive assays","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2022.105375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105375"}}